Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial by Apolo, Andrea B, MD, Nadal, Rosa, MD, Tomita, Yusuke, MD, Davarpanah, Nicole N, MD, Cordes, Lisa M, PharmD, Steinberg, Seth M, PhD, Cao, Liang, PhD, Parnes, Howard L, MD, Costello, Rene, BS, Merino, Maria J, MD, Folio, Les R, DO, Lindenberg, Liza, MD, Raffeld, Mark, MD, Lin, Jeffrey, MD, Lee, Min-Jung, PhD, Lee, Sunmin, MS, Alarcon, Sylvia V, MD, Yuno, Akira, PhD, Dawson, Nancy A, MD, Allette, Kimaada, BS, Roy, Arpita, PhD, De Silva, Dinuka, PhD, Lee, Molly M, PhD, Sissung, Tristan M, PhD, Figg, William D, PharmD, Agarwal, Piyush K, MD, Wright, John J, MD, Ning, Yangmin M, MD, Gulley, James L, MD, Dahut, William L, MD, Bottaro, Donald P, PhD, Trepel, Jane B

Get full text